Skip to content

Clinical trials

Completed Multiple Sclerosis, Relapsing-Remitting trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Status: Completed Country / region: Switzerland Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20061
20073
20082
20093
20103
20111
20121
20132
20141
20161
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen5
Bayer3
Novartis Pharmaceuticals2
Cellerys AG1
Chiara Zecca1
Claudio Gobbi1
EMD Serono1
EMD Serono Research & Development Institute, Inc.1
Genentech, Inc.1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting23
Multiple Sclerosis8
Recurrence2
Demyelinating Diseases1
Diffuse Cerebral Sclerosis of Schilder1
Lower Urinary Tract Symptoms1
Neuromyelitis Optica1
Urinary Bladder, Overactive1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.